Post-hoc Analysis of the Effects of Belimumab on Musculoskeletal Organ Manifestations in BILAG in the Phase-3-Trials with Belimumab

被引：0
|
作者：
Hiepe, F. [1 ]
Fischer-Betz, R. [2 ]
Schwarting, A. [3 ,4 ]
机构：
[1] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-13353 Berlin, Germany
[2] Univ Dusseldorf, Poliklin Rheumatol, Dusseldorf, Germany
[3] Univ Mainz Klinikum, Bad Kreuznach, Germany
[4] ACURA Rheumazentrum Rheinland Pfalz AG, Bad Kreuznach, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [21] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, P. J.
    Kavanaugh, A.
    Gladman, D. D.
    Fitzgerald, O.
    Soriano, E.
    Nash, P.
    Feng, D.
    Lertratanakul, A.
    Douglas, K.
    Lippe, R.
    Gossec, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1294 - 1295
  • [22] Sustainability of Linaclotide Response in Chronic Idiopathic Constipation Patients: A Post-hoc Pooled Analysis of Two Phase 3 Trials
    Lavins, Bernard J.
    Fox, Susan M.
    Reasner, David
    Tripp, Kenneth
    Shea, Elizabeth P.
    Blakesley, Rick
    Shiff, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S746 - S747
  • [23] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Gladman, Dafna
    Kavanaugh, Arthur
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    Mease, Philip
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1115
  • [24] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    Fitzgerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinva
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laura
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 45 - 45
  • [26] CAN THE SLE-DAS SUBSTITUTE BILAG TO MEASURE LUPUS DISEASE ACTIVITY IN CLINICAL TRIALS? POST-HOC ANALYSIS OF THE BLISS-76 TRIAL
    Jesus, D.
    Matos, A.
    Henriques, C.
    Doria, A.
    Ines, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 634 - 635
  • [27] Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study
    Urowitz, Murray B.
    Ohsfeldt, Robert L.
    Wielage, Ronald C.
    Dever, John J.
    Zakerifar, Mehdi
    Asukai, Yumi
    Ramachandran, Sulabha
    Joshi, Ashish, V
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [28] Effects of Cenobamate on Weight: Post-hoc Analyses of Global Phase 2 and 3 Studies
    Ferrari, Louis
    Rosenfeld, William
    NEUROLOGY, 2023, 100 (17)
  • [29] BARICITINIB EFFICACY IN MODERATE RHEUMATOID ARTHRITIS - A POST-HOC ANALYSIS FROM TWO PHASE III TRIALS
    Kirkham, Bruce W.
    Nikiphorou, Elena
    Edwards, Christopher J.
    Sheesh, Mohamed
    Haladyj, Ewa
    Gerwien, Jens
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    RHEUMATOLOGY, 2023, 62
  • [30] Association Between Knee Osteoarthritis Pain and Concomitant Drug Use: A Post-hoc Analysis of Two Phase 3 Clinical Trials
    Miller, Claire
    Baker, Matthew
    Alexandersen, Peter
    Mondragon, Alejandro
    Adrian, Ida Sofie
    Karsdal, Morten
    Andersen, Jeppe
    Bihlet, Asger
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3950 - 3952
12345